官方服务：
资源简介：
Neoadjuvant chemotherapy first and second breast cancer
应用场景：
创建时间：
2026-03-05
相关数据集
Additional file 4: of On-treatment biomarkers can improve prediction of response to neoadjuvant chemotherapy in breast cancer
Table S1. Gene lists of pairwise analysis of pre- and on-treatment sequential patient-matched samples from NEO and I-SPY datasets using Significance analysis of microarrays with FDR = 10%. Table S2. G
Figshare2019-06-14 更新50
Table S9 from Interaction between Molecular Subtypes and Stromal Immune Infiltration before and after Treatment in Breast Cancer Patients Treated with Neoadjuvant Chemotherapy
Table S9
NIAID Data Ecosystem30
Clinical and pathologic characteristics of LABC patients receiving neo-adjuvant chemotherapy.
Clinical and pathologic characteristics of LABC patients receiving neo-adjuvant chemotherapy.
Figshare2018-01-04 更新20
DataSheet_1_Long-Term Cardiac Safety and Survival Outcomes of Neoadjuvant Pegylated Liposomal Doxorubicin in Elderly Patients or Prone to Cardiotoxicity and Triple Negative Breast Cancer. Final Results of the Multicentre Phase II CAPRICE Study.docx
BackgroundThe CAPRICE trial was designed to specifically evaluate neoadjuvant pegylated liposomal doxorubicin (PLD) in elderly patients or in those with other cardiovascular risk factors in whom conve
NIAID Data Ecosystem40
Table_2_Long-Term Cardiac Safety and Survival Outcomes of Neoadjuvant Pegylated Liposomal Doxorubicin in Elderly Patients or Prone to Cardiotoxicity and Triple Negative Breast Cancer. Final Results of the Multicentre Phase II CAPRICE Study.docx
BackgroundThe CAPRICE trial was designed to specifically evaluate neoadjuvant pegylated liposomal doxorubicin (PLD) in elderly patients or in those with other cardiovascular risk factors in whom conve
NIAID Data Ecosystem30
